Published in Infect Immun on April 01, 1995
The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A (1998) 3.83
Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev (2003) 3.70
Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother (1998) 3.45
Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta (2007) 3.24
Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J (1999) 2.93
A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides. J Bacteriol (2000) 2.26
Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun (2000) 2.24
The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proc Natl Acad Sci U S A (2009) 2.07
Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut (2003) 1.97
Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun (2003) 1.90
Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun (1999) 1.87
Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun (2002) 1.80
Antimicrobial polypeptides in host defense of the respiratory tract. J Clin Invest (2002) 1.67
Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells. Infect Immun (2007) 1.38
Antimicrobial peptides. Pharmaceuticals (Basel) (2013) 1.37
The role of antimicrobial peptides at the ocular surface. Ophthalmic Res (2008) 1.32
Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob Agents Chemother (2005) 1.28
Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? Int J Antimicrob Agents (2011) 1.28
Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia. Infect Immun (1998) 1.24
Human antimicrobial peptides and proteins. Pharmaceuticals (Basel) (2014) 1.23
Phenylbutyrate induces antimicrobial peptide expression. Antimicrob Agents Chemother (2009) 1.21
Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins. J Immunol (2009) 1.21
Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia. J Immunol (2012) 1.20
Host defense peptides in the oral cavity and the lung: similarities and differences. J Dent Res (2008) 1.19
Antimicrobial peptides in human skin disease. Eur J Dermatol (2007) 1.17
Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease. J Immunol (2013) 1.15
Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils. Eur J Immunol (2009) 1.14
Antibacterial activities of rhodamine B-conjugated gelsolin-derived peptides compared to those of the antimicrobial peptides cathelicidin LL37, magainin II, and melittin. Antimicrob Agents Chemother (2004) 1.13
Biophysical characterization of endotoxin inactivation by NK-2, an antimicrobial peptide derived from mammalian NK-lysin. Antimicrob Agents Chemother (2004) 1.11
A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides. PLoS Pathog (2011) 1.10
Host defense peptides in wound healing. Mol Med (2008) 1.10
Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells. Mol Cancer Res (2009) 1.10
Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin Diagn Lab Immunol (2002) 1.10
Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrob Agents Chemother (2001) 1.10
Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infect Immun (1999) 1.09
Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages. Cell Microbiol (2005) 1.08
Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? Int J Mol Sci (2009) 1.08
Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model. Antimicrob Agents Chemother (1998) 1.06
High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments. Biochim Biophys Acta (2014) 1.05
Regulation of cathelicidin gene expression: induction by lipopolysaccharide, interleukin-6, retinoic acid, and Salmonella enterica serovar typhimurium infection. Infect Immun (2000) 1.05
Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens. Antimicrob Agents Chemother (2013) 1.03
Doxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related peptidases and activation of cathelicidin. J Invest Dermatol (2012) 1.02
Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf (2004) 1.00
Vitamin D-mediated induction of innate immunity in gingival epithelial cells. Infect Immun (2011) 0.99
Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial. Crit Care Med (2015) 0.99
Inhibition of multidrug-resistant Acinetobacter baumannii by nonviral expression of hCAP-18 in a bioengineered human skin tissue. Mol Ther (2009) 0.98
Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults. BMC Res Notes (2012) 0.97
In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37. Antimicrob Agents Chemother (2006) 0.97
Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes. Infect Immun (1997) 0.96
LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalents. Antimicrob Agents Chemother (2014) 0.94
Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence. Antimicrob Agents Chemother (2006) 0.94
Differing effects of exogenous or endogenous cathelicidin on macrophage toll-like receptor signaling. Immunol Cell Biol (2009) 0.93
Antimicrobial peptide killing of African trypanosomes. Parasite Immunol (2011) 0.92
Antimicrobial peptides in periodontal innate defense. Front Oral Biol (2011) 0.91
Expression and modulation of LL-37 in normal human keratinocytes, HaCaT cells, and inflammatory skin diseases. J Korean Med Sci (2005) 0.91
Interaction of the gelsolin-derived antibacterial PBP 10 peptide with lipid bilayers and cell membranes. Antimicrob Agents Chemother (2006) 0.90
Microarray analysis of host gene expression for comparison between naïve and HSV-1 latent rabbit trigeminal ganglia. Mol Vis (2008) 0.89
A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media. Mol Immunol (2006) 0.89
Expression and secretion of cathelicidin LL-37 in human epithelial cells after infection by Mycobacterium bovis Bacillus Calmette-Guérin. Clin Vaccine Immunol (2008) 0.89
Interaction of NK lysin, a peptide produced by cytolytic lymphocytes, with endotoxin. Infect Immun (1999) 0.88
Structural and functional analysis of horse cathelicidin peptides. Antimicrob Agents Chemother (2001) 0.87
Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study. BMC Cardiovasc Disord (2006) 0.87
Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation. PLoS Negl Trop Dis (2013) 0.87
Determination of the antibacterial and lipopolysaccharide-neutralizing regions of guinea pig neutrophil cathelicidin peptide CAP11. Antimicrob Agents Chemother (2006) 0.86
Evidence of an antimicrobial-immunomodulatory role of Atlantic salmon cathelicidins during infection with Yersinia ruckeri. PLoS One (2011) 0.86
Structural and functional analysis of the pro-domain of human cathelicidin, LL-37. Biochemistry (2013) 0.85
The host defense peptide LL-37 selectively permeabilizes apoptotic leukocytes. Antimicrob Agents Chemother (2008) 0.85
Antibacterial activity of the human host defence peptide LL-37 and selected synthetic cationic lipids against bacteria associated with oral and upper respiratory tract infections. J Antimicrob Chemother (2012) 0.85
Epithelial antimicrobial peptides: guardian of the oral cavity. Int J Pept (2014) 0.85
Mechanisms Underlying the Regulation of Innate and Adaptive Immunity by Vitamin D. Nutrients (2015) 0.84
Role of host-defence peptides in eye diseases. Cell Mol Life Sci (2011) 0.84
Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis. Infect Immun (2009) 0.84
Effect of anticoagulants on binding and neutralization of lipopolysaccharide by the peptide immunoglobulin conjugate CAP18(106-138)-immunoglobulin G in whole blood. Infect Immun (1997) 0.84
Defensin production by human limbo-corneal fibroblasts infected with mycobacteria. Pathogens (2013) 0.83
Cathelicidin gene expression in porcine tissues: roles in ontogeny and tissue specificity. Infect Immun (1999) 0.83
Dimerization of a cell-penetrating peptide leads to enhanced cellular uptake and drug delivery. Beilstein J Org Chem (2012) 0.82
Human antimicrobial proteins in ear wax. Eur J Clin Microbiol Infect Dis (2011) 0.81
Regulation of the human cathelicidin antimicrobial peptide gene by 1α,25-dihydroxyvitamin D3 in primary immune cells. J Steroid Biochem Mol Biol (2014) 0.81
Regulation of antimicrobial peptide gene expression by nutrients and by-products of microbial metabolism. Eur J Nutr (2012) 0.81
Antimicrobial action of rabbit leukocyte CAP18(106-137). Antimicrob Agents Chemother (1997) 0.81
Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria. PLoS One (2015) 0.81
Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans. J Immunol (2016) 0.80
Sphingolipids and antimicrobial peptides: function and roles in atopic dermatitis. Biomol Ther (Seoul) (2013) 0.80
Modulation of neutrophil apoptosis by antimicrobial peptides. ISRN Microbiol (2012) 0.80
Bioengineered human skin: working the bugs out. Mol Ther (2009) 0.79
Ixodes scapularis Tick Saliva Proteins Sequentially Secreted Every 24 h during Blood Feeding. PLoS Negl Trop Dis (2016) 0.78
LL-37 stimulates the functions of adipose-derived stromal/stem cells via early growth response 1 and the MAPK pathway. Stem Cell Res Ther (2016) 0.78
Ultrashort cationic lipopeptides and lipopeptoids selectively induce cytokine production in macrophages. PLoS One (2013) 0.78
Interspecies cathelicidin comparison reveals divergence in antimicrobial activity, TLR modulation, chemokine induction and regulation of phagocytosis. Sci Rep (2017) 0.77
Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation. ChemMedChem (2015) 0.77
Defense peptides secreted by helminth pathogens: antimicrobial and/or immunomodulator molecules? Front Immunol (2012) 0.77
Lipopolysaccharide Phosphorylation by the WaaY Kinase Affects the Susceptibility of Escherichia coli to the Human Antimicrobial Peptide LL-37. J Biol Chem (2015) 0.76
Vitamin D Activation and Function in Human Corneal Epithelial Cells During TLR-Induced Inflammation. Invest Ophthalmol Vis Sci (2015) 0.76
Design and Application of Antimicrobial Peptide Conjugates. Int J Mol Sci (2016) 0.76
Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis. Clin Immunol (2016) 0.76
Towards a paradigm shift in innate immunity-seminal work by Hans G. Boman and co-workers. Philos Trans R Soc Lond B Biol Sci (2016) 0.76
Circulating Cathelicidin Concentrations in a Cohort of Healthy Children: Influence of Age, Body Composition, Gender and Vitamin D Status. PLoS One (2016) 0.75
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem (1982) 27.26
CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (1990) 17.86
Structure and function of lipopolysaccharide binding protein. Science (1990) 7.76
Agents that increase the permeability of the outer membrane. Microbiol Rev (1992) 7.52
Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A (1979) 6.77
Endotoxins and disease mechanisms. Annu Rev Med (1987) 6.07
Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem (1988) 5.75
Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol (1993) 5.36
Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med (1990) 5.15
Polymyxin and related peptide antibiotics. Annu Rev Biochem (1977) 4.53
The pathogenesis of sepsis. Ann Intern Med (1991) 4.34
Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med (1982) 4.28
Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med (1986) 3.84
Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem (1985) 3.58
Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate. Infect Immun (1984) 3.32
NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci U S A (1990) 3.28
Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship. J Biol Chem (1979) 3.15
Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide. Nature (1983) 2.84
Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J Exp Med (1991) 2.77
A proposed mechanism for natural immunity to enterobacterial pathogens. J Immunol (1968) 2.66
A simple method for the quantitation of submicrogram amounts of bacterial endotoxin. Proc Soc Exp Biol Med (1970) 2.53
Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc Natl Acad Sci U S A (1991) 2.24
Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J Biol Chem (1992) 2.21
High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun (1992) 2.17
A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J Exp Med (1991) 2.14
The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol (1992) 1.92
Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. J Infect Dis (1985) 1.84
Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J Clin Invest (1992) 1.82
A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. J Biol Chem (1988) 1.79
Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect Immun (1994) 1.78
Primary structure of a new cysteine proteinase inhibitor from pig leucocytes. FEBS Lett (1989) 1.50
Antibacterial 15-kDa protein isoforms (p15s) are members of a novel family of leukocyte proteins. J Biol Chem (1993) 1.48
Synthetic bactericidal peptide based on CAP37: a 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes. Proc Natl Acad Sci U S A (1993) 1.45
Antimicrobial activity of rabbit CAP18-derived peptides. Antimicrob Agents Chemother (1993) 1.40
A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J Immunol (1994) 1.39
Stimulus-induced maturation of probactenecins, precursors of neutrophil antimicrobial polypeptides. J Immunol (1991) 1.31
Complementary DNA sequence of rabbit CAP18--a unique lipopolysaccharide binding protein. Biochem Biophys Res Commun (1991) 1.30
Identification of a new member of the protegrin family by cDNA cloning. FEBS Lett (1994) 1.22
cDNA cloning of the neutrophil bactericidal peptide indolicidin. Biochem Biophys Res Commun (1992) 1.21
Amino acid sequences of two proline-rich bactenecins. Antimicrobial peptides of bovine neutrophils. J Biol Chem (1990) 1.18
A 28 kDa protein of normal mouse serum binds lipopolysaccharides of gram-negative and lipoteichoic acids of gram-positive bacteria. Microb Pathog (1990) 1.18
Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes. FEBS Lett (1994) 1.16
Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid cDNA. FEBS Lett (1994) 1.13
Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity. Infect Immun (1994) 1.12
Leukocytic antimicrobial peptides kill autoimmune T cells. J Neuroimmunol (1993) 1.07
The cDNA of the neutrophil antibiotic Bac5 predicts a pro-sequence homologous to a cysteine proteinase inhibitor that is common to other neutrophil antibiotics. J Biol Chem (1993) 1.07
Antimicrobial binding of a radiolabeled cationic neutrophil granule protein. Infect Immun (1987) 1.06
Investigation of endotoxin binding cationic proteins from granulocytes; agglutination of erythrocytes sensitized with Re-LPS. Adv Exp Med Biol (1990) 1.03
COOH-terminal signals mediate the trafficking of a peptide processing enzyme in endocrine cells. J Cell Biol (1993) 1.03
A novel cDNA sequence encoding a pig leukocyte antimicrobial peptide with a cathelin-like pro-sequence. Biochem Biophys Res Commun (1993) 0.99
Bactenecin, a leukocytic antimicrobial peptide, is cytotoxic to neuronal and glial cells. J Neurosci Res (1993) 0.97
Bactericidal/permeability-increasing protein ameliorates acute lung injury in porcine endotoxemia. J Appl Physiol (1985) (1994) 0.95
Pig leukocyte cysteine proteinase inhibitor (PLCPI), a new member of the stefin family. FEBS Lett (1993) 0.89
Molecular cloning of a putative homolog of proline/arginine-rich antibacterial peptides from porcine bone marrow. FEBS Lett (1993) 0.84
Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock. Prog Clin Biol Res (1991) 0.83
A protein interaction map of Drosophila melanogaster. Science (2003) 20.06
Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (1984) 17.70
The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc (1999) 14.47
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science (2001) 11.56
Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96
Sequence and analysis of chromosome 2 of the plant Arabidopsis thaliana. Nature (1999) 8.04
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis (2008) 6.97
Guided medication dosing for inpatients with renal insufficiency. JAMA (2001) 6.25
Structure and function of a new STAT-induced STAT inhibitor. Nature (1997) 6.02
The earliest angiosperms: evidence from mitochondrial, plastid and nuclear genomes. Nature (1999) 5.85
Odds ratio or relative risk for cross-sectional data? Int J Epidemiol (1994) 5.27
Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science (1994) 5.20
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Prevention of fat-induced insulin resistance by salicylate. J Clin Invest (2001) 4.74
Structure and functional expression of a human interleukin-8 receptor. Science (1991) 4.74
Estimation of prevalence rate ratios for cross sectional data: an example in occupational epidemiology. Br J Ind Med (1993) 4.41
Identification of heregulin, a specific activator of p185erbB2. Science (1992) 4.17
Effect of low concentrations of ozone on inhaled allergen responses in asthmatic subjects. Lancet (1991) 3.92
WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A (1998) 3.73
Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature (1997) 3.64
Exact confidence interval of the SMR based on prevalence data. Int J Epidemiol (1994) 3.62
Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med (1998) 3.59
Proliferation of mutators in A cell population. J Bacteriol (1997) 3.55
Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA (2001) 3.55
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res (1997) 3.38
Dietary effects on breast-cancer risk in Singapore. Lancet (1991) 3.32
The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res (2001) 3.30
A case of concomitant tuberculosis and sarcoidosis with mycobacterial DNA present in the sarcoid lesion. Chest (1998) 3.25
T-DNA insertional mutagenesis for functional genomics in rice. Plant J (2000) 3.25
Prostaglandin D2 as a mediator of allergic asthma. Science (2000) 3.19
The H2O2 stimulon in Saccharomyces cerevisiae. J Biol Chem (1998) 3.19
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature (1997) 3.07
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res (2000) 3.03
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol (1990) 2.99
Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc (2001) 2.98
Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord (2003) 2.89
Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol (2001) 2.86
Evidence-based disease management. JAMA (1997) 2.85
IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J (2001) 2.84
Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene (2008) 2.83
Smaller inner ear sensory epithelia in Neurog 1 null mice are related to earlier hair cell cycle exit. Dev Dyn (2005) 2.71
Inositol 1,4,5-trisphosphate releases Ca2+ from intracellular store sites in skinned single cells of porcine coronary artery. Biochem Biophys Res Commun (1984) 2.71
Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A (1996) 2.70
Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes. Cancer Res (2001) 2.68
Protein structure prediction by global optimization of a potential energy function. Proc Natl Acad Sci U S A (1999) 2.66
The Otto E. Aufranc Award: The role of labral lesions to development of early degenerative hip disease. Clin Orthop Relat Res (2001) 2.63
Qualitative interview study of communication between parents and children about maternal breast cancer. BMJ (2000) 2.60
Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis. Am J Pathol (1999) 2.59
Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation (2001) 2.59
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum Mol Genet (1998) 2.57
Forces exerted by locomoting cells. Semin Cell Biol (1994) 2.53
A delicate balance: homeostatic control of copper uptake and distribution. J Nutr (1999) 2.52
Family history and perceived vulnerability to some common diseases: a study of young people and their parents. J Med Genet (1996) 2.49
Local application of retinoic acid to the limb bond mimics the action of the polarizing region. Nature (1982) 2.48
Intravascular susceptibility contrast mechanisms in tissues. Magn Reson Med (1994) 2.48
A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. J Biol Chem (1987) 2.48
Phytochrome signalling is mediated through nucleoside diphosphate kinase 2. Nature (1999) 2.46
Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol (1997) 2.44
Theoretical model for water diffusion in tissues. Magn Reson Med (1995) 2.43
Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor. Development (2001) 2.43
Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey 2001. Diabetes Care (2006) 2.35
Pain after breast surgery: a survey of 282 women. Pain (1996) 2.33
Recent improvements in prediction of protein structure by global optimization of a potential energy function. Proc Natl Acad Sci U S A (2001) 2.31
The vitamin B12 analog cobinamide is an effective hydrogen sulfide antidote in a lethal rabbit model. Clin Toxicol (Phila) (2014) 2.31
Factors affecting the relationship between childhood and adult cholesterol levels: the Muscatine Study. Pediatrics (1988) 2.31
Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies. J Virol (1998) 2.28
Failure of parturition in mice lacking the prostaglandin F receptor. Science (1997) 2.27
Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science (1998) 2.26
Inhibition of PMA-induced, LFA-1-dependent lymphocyte aggregation by ADP ribosylation of the small molecular weight GTP binding protein, rho. J Cell Biol (1993) 2.26
DNA cleavage in trans by the active site tyrosine during Flp recombination: switching protein partners before exchanging strands. Cell (1992) 2.22
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer (2008) 2.21
Inositol 1,4,5-trisphosphate activates pharmacomechanical coupling in smooth muscle of the rabbit mesenteric artery. J Physiol (1986) 2.20
Optimising delivery of care in coeliac disease - comparison of the benefits of repeat biopsy and serological follow-up. Aliment Pharmacol Ther (2013) 2.18
Cytotoxic mechanism of tumor necrosis factor-alpha. FASEB J (1990) 2.17
RIP3, a novel apoptosis-inducing kinase. J Biol Chem (1999) 2.15
MAC1, a nuclear regulatory protein related to Cu-dependent transcription factors is involved in Cu/Fe utilization and stress resistance in yeast. EMBO J (1993) 2.13
Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax (2004) 2.13
Complications of inguinoscrotal bladder hernias: a case series. Hernia (2008) 2.12
Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor. Proc Natl Acad Sci U S A (1994) 2.10
Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation (1996) 2.10
Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase. J Biol Chem (2000) 2.09
Inducible repair of thymine glycol detected by an ultrasensitive assay for DNA damage. Science (1998) 2.08
Group II introns as controllable gene targeting vectors for genetic manipulation of bacteria. Nat Biotechnol (2001) 2.06
The role of MDM2 in the proliferative activity of ameloblastoma. Oral Oncol (2002) 2.04
Association of intracranial atherosclerotic stenosis with severity of white matter hyperintensities. Eur J Neurol (2014) 2.02
Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl. Science (1995) 1.99
Pregnancy and addiction. A comprehensive care model. J Subst Abuse Treat (1997) 1.99
Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther (2009) 1.98
Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens. Chest (2000) 1.96
Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors. Science (2000) 1.95
A role for inositol 1,4,5-trisphosphate in the initiation of agonist-induced contractions of dog tracheal smooth muscle. Br J Pharmacol (1985) 1.94
Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol (1999) 1.93
Adenyl cyclase of Brevibacterium liquefaciens. Biochim Biophys Acta (1967) 1.93
Release of Ca2+ from a non-mitochondrial store site in peritoneal macrophages treated with saponin by inositol 1,4,5-trisphosphate. Biochem J (1984) 1.92
Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization. Mol Cell Biol (1999) 1.91
Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol (2002) 1.90